Mineralys Therapeutics Inc (NAS:MLYS)
$ 30.4 -0.050 (-0.16%) Market Cap: 2.68 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 37/100

Mineralys Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 04:20 PM GMT
Release Date Price: $29.26 (-1.58%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MLYS.OQ - Mineralys Therapeutics Inc
Mineralys Therapeutics Inc at Bank of America Global Healthcare Conference
May 12, 2026 / 04:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
X. From Mineralis, I have here with me today, John Congleton. John, thanks for joining us.

I'm just going to hand it over to John for some opening remarks before we dive into some Q&A.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, Dana. I appreciate it. Appreciate the opportunity to participate in the Bank of America Conference. It was a positive conference for us. So John Congleton, CEO of Mineralis, we had a very productive year and a half, I would say.

Last year with a lot of data readouts culminating in the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot